SCHEMBL6432383

CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)O.[Pb+4]

nearest known ligand 0.73

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	17/20	0.72

▸	CCKBR	P32239	1/20	0.71

▸	GCGR	P47871	5/20	0.70

▸	GIPR	P48546	1/20	0.69

▸	NR3C1	P04150	2/20	0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL4755	1.00	GLP1R (0.72)	GLP1RCCKBRGCGRGIPRNR3C1
SCHEMBL23721788	1.00	GLP1R (0.72)	GLP1RCCKBRGCGRGIPRNR3C1
Zinc Ion SCHEMBL3043764	0.99	GLP1R (0.72)	GLP1RCCKBRGCGRGIPRNR3C1
Hydrochloric Acid SCHEMBL20883	0.99	GLP1R (0.72)	GLP1RCCKBRGCGRGIPRNR3C1
Glycine SCHEMBL9450801	0.99	GLP1R (0.72)	GLP1RCCKBRGCGRGIPRNR3C1
SCHEMBL30721605	0.99	GLP1R (0.73)	GLP1RCCKBRGCGRGIPRNR3C1
Acetic Acid SCHEMBL4351476	0.99	GLP1R (0.71)	GLP1RCCKBRGCGRGIPRNR3C1
Hydrochloric Acid SCHEMBL4743028	0.99	GLP1R (0.71)	GLP1RCCKBRGCGRGIPRNR3C1
Hydrochloric Acid SCHEMBL4743032	0.99	GLP1R (0.71)	GLP1RCCKBRGCGRGIPRNR3C1
SCHEMBL20945961	0.98	GLP1R (0.71)	GLP1RCCKBRGCGRGIPRNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2021064107-A1	COMPOSITION COMPRISING SOY AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF MICROVASCULAR OR LIPOPROTEIN RELATED DISEASES, MICROCARDIOVASCULAR DISEASES, ATHEROSCLEROSIS, HYPERTENSION, AND IN PATIENTS WITH SUCH CARDIOVASCULAR DISORDERS SUFFERING FROM ALZHEIMER AND DEMENTIA, OVERWEIGHT AND OBESITY, TYPE 2 DIABETES, ASTHMA AND OTHER DISORDERS	NORVIA NUTRITION LTD. (IE)	2021-04-08	—	—	WO	disclosed
WO-2003004039-A9	COMPOSITION COMPRISING SOY AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF VARIOUS DISEASES	NUTRI PHARMA DANMARK HOLDING A (DK)	2005-05-26	—	—	WO	disclosed
US-20040234631-A1	Composition comprising soy and use thereof in the provention and/or treatment of various diseases	NUTRI PHARMA ASA (NO)	2004-11-25	—	—	US	disclosed
EP-1443946-A2	COMPOSITION COMPRISING SOY AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF VARIOUS DISEASES	Nutri Pharma ASA (NO)	2004-08-11	—	—	EP	disclosed
EP-1143988-B1	COMPOSITION COMPRISING SOY PROTEIN, DIETARY FIBRES AND A PHYTOESTROGEN COMPOUND AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF TYPE 2 DIABETES, THE METABOLIC SYNDROME AND ASSOCIATED CARDIOVASCULAR DISEASES	NUTRI PHARMA AS (NO)	2004-02-18	—	—	EP	disclosed
US-20030113390-A1	Composition comprising soy protein, dietary fibers and a phytoestrogen compound and use thereof in the prevention and/or treatment of various diseases	HOIE LARS HENRIK (GB)	2003-06-19	—	—	US	disclosed
WO-2003004039-A2	COMPOSITION COMPRISING SOY AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF VARIOUS DISEASES	NUTRI PHARMA DANMARK HOLDING A/S (DK)	2003-01-16	—	—	WO	disclosed
EP-1143988-A1	COMPOSITION COMPRISING SOY PROTEIN, DIETARY FIBRES AND A PHYTOESTROGEN COMPOUND AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF TYPE 2 DIABETES, THE METABOLIC SYNDROME AND ASSOCIATED CARDIOVASCULAR DISEASES	Nutri Pharma ASA (NO)	2001-10-17	—	—	EP	disclosed
WO-2000030663-A1	COMPOSITION COMPRISING SOY PROTEIN, DIETARY FIBRES AND A PHYTOESTROGEN COMPOUND AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF TYPE 2 DIABETES, THE METABOLIC SYNDROME AND ASSOCIATED CARDIOVASCULAR DISEASES	NUTRI PHARMA ASA (NO)	2000-06-02	—	—	WO	disclosed